4Mosea L, Appel LJ, Benjamin EJ, et al. Evidence - based guidefines for cardiovascular disease prevention in women[J]. Circulation, 2004,109 (5) : 672 - 693
5Cheng CI,Yeh KH,Chang HW,et al. Comparison of baseline characteristics, clinical features, angiographie results, and early outcomes in men vs. Women with acute myocardial infarction undergoing primary coronary intervention[J]. Chest, 2004,126(1) :47 - 53
二级参考文献7
1Ryan TJ, Antman EM, Brooks NH, et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiolagy/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction ). J Am Coll Cardiol,1999,34:890-911.
2Janczak J, Krupienicz A, Roszczyk E, et al. PRIMARY CORONARY ANGIOPLASTY versus THROMBOLYTIC THERAPY. Comparison of mortality in the acute phase of myocardial infarction - a single centre experience. Kardiol Pol, 2002,57:542-550.
3Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevatian myocardial infarction: a report of the American College of Cardiolagy/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation ,2004,110 : e82-292.
4Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet,2001,357 : 1385-1390.
5ISIS-4 ( Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral monanitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet,1995, 345,669 -685.
6Collins R, Peto R, Baigent C, et al. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. N Engl J Med, 1997,336:847-860.
